Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies
暂无分享,去创建一个
Thomas Hambrock | Jelle O. Barentsz | Henkjan J. Huisman | H. Huisman | J. Barentsz | T. Hambrock | W. J. M. Ven | Wendy J. M. Ven | Christina A. Hulsbergen–van de Kaa | C. Hulsbergen–van de Kaa
[1] T. Wheeler,et al. Heterogeneity of prostate cancer in radical prostatectomy specimens. , 1994, Urology.
[2] Thomas Hambrock,et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.
[3] Tsuyoshi Mitake,et al. Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.
[4] D. Parkin,et al. Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.
[5] Thomas Hambrock,et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.
[6] D J Ruiter,et al. HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.
[7] Peter Guion,et al. Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.
[8] S. Verma,et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.
[9] A. Fenster,et al. Assessment of image registration accuracy in three-dimensional transrectal ultrasound guided prostate biopsy. , 2010, Medical physics.
[10] J. Epstein. An update of the Gleason grading system. , 2010, The Journal of urology.
[11] Aytekin Oto,et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.
[12] Zeike A. Taylor,et al. MR to ultrasound registration for image-guided prostate interventions , 2012, Medical Image Anal..
[13] William J Catalona,et al. Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.
[14] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[15] H. Kretschmer. Transactions of the Philadelphia Branch of the American Urological Association: Urological Problems in Infancy and Childhood , 1927 .
[16] Sheng Xu,et al. Realtime TRUS/MRI Fusion Targeted-Biopsy for Prostate Cancer: A Clinical Demonstration of Increased Positive Biopsy Rates , 2010, Prostate Cancer Imaging.
[17] N M deSouza,et al. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.
[18] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[19] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[20] 佐藤 千峰,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2006 .
[21] S. Fosså,et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.
[22] Katsuyoshi Ito,et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.
[23] H. Shinmoto,et al. Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.
[24] Namkug Kim,et al. Apparent diffusion coefficient: Prostate cancer versus noncancerous tissue according to anatomical region , 2008, Journal of magnetic resonance imaging : JMRI.
[25] A. Jemal,et al. Global Cancer Statistics , 2011 .
[26] P. Box. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer , 2011 .
[27] M. Soloway,et al. Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. , 2008, Urology.
[28] Katsuyuki Nakanishi,et al. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer? , 2011, Journal of magnetic resonance imaging : JMRI.